ArriVent BioPharma, Inc. SEC filings AVBP
ArriVent BioPharma, Inc. has 160 filings in SEC EDGAR's recent list, going back to Jun 23, 2021. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2026 | — |
| 4 | Insider transaction | Nov 2, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 26, 2026 | Oct 25, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 19, 2026 | Oct 19, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 13, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 13, 2026 | Oct 12, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 8, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 6, 2026 | Oct 6, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Results of operations
|
Aug 12, 2026 | Aug 11, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 27, 2026 | — |
| 4 | Insider transaction | Jun 22, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Other events
|
May 11, 2026 | May 11, 2026 |
| 424B5 | Prospectus supplement | May 11, 2026 | — |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 11, 2026 | May 11, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 6, 2026 | — |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 17, 2026 | Mar 17, 2026 |
| S-8 | Employee stock plan registration | Mar 5, 2026 | — |
| 10-K | Annual report | Mar 5, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2026 | Mar 5, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 5, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Dec 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 30, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 21, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 30, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 17, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 15, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 9, 2025 | Sep 9, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 13, 2025 | — |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Other events
|
Jul 21, 2025 | Jul 21, 2025 |
| 4 | Insider transaction | Jul 15, 2025 | Jul 11, 2025 |
| 424B5 | Prospectus supplement | Jul 2, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jul 2, 2025 | Jul 1, 2025 |
| 424B5 | Prospectus supplement | Jul 1, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 23, 2025 | Jun 23, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2025 | Jun 18, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| 4 | Insider transaction | Apr 29, 2025 | Apr 28, 2025 |
| 3 | Initial insider ownership | Apr 29, 2025 | Apr 28, 2025 |
| ARS | Annual report to shareholders | Apr 28, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 28, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 28, 2025 | Apr 23, 2025 |
| 8-K |
Current report
Auditor change
|
Mar 13, 2025 | Mar 11, 2025 |
| S-8 | Employee stock plan registration | Mar 3, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 3, 2025 | Mar 3, 2025 |
| 10-K | Annual report | Mar 3, 2025 | Dec 31, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| 4 | Insider transaction | Feb 14, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 3, 2025 |
| S-3ASR | Automatic shelf registration | Feb 3, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 22, 2025 | Jan 21, 2025 |
| SC 13G | Ownership over 5% (passive) | Dec 4, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 24, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 11, 2024 | — |
| 4 | Insider transaction | Sep 23, 2024 | Sep 19, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 9, 2024 | Sep 9, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K/A |
Amended current report
Officer or director change
|
Jul 9, 2024 | May 16, 2024 |
| 8-K/A |
Amended current report
Officer or director change
|
Jul 9, 2024 | Apr 20, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 5, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 16, 2024 |
| 3 | Initial insider ownership | May 20, 2024 | May 16, 2024 |
| 8-K |
Current report
Officer or director change
|
May 16, 2024 | May 16, 2024 |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| 4 | Insider transaction | Apr 23, 2024 | Apr 22, 2024 |
| 3 | Initial insider ownership | Apr 23, 2024 | Apr 20, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 22, 2024 | Apr 20, 2024 |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2024 | Mar 28, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13D | Ownership over 5% (active) | Feb 5, 2024 | — |
| S-8 | Employee stock plan registration | Feb 2, 2024 | — |
| 4 | Insider transaction | Feb 1, 2024 | Jan 30, 2024 |
| 4 | Insider transaction | Jan 31, 2024 | Jan 30, 2024 |
| 4 | Insider transaction | Jan 31, 2024 | Jan 30, 2024 |
| 4 | Insider transaction | Jan 31, 2024 | Jan 30, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jan 30, 2024 | Jan 30, 2024 |
| 4 | Insider transaction | Jan 29, 2024 | Jan 25, 2024 |
| 4 | Insider transaction | Jan 29, 2024 | Jan 25, 2024 |
| SEC STAFF LETTER | Filing | Jan 26, 2024 | — |
| 424B4 | Prospectus | Jan 26, 2024 | — |
| EFFECT | Filing | Jan 25, 2024 | — |
| 3 | Initial insider ownership | Jan 25, 2024 | Jan 25, 2024 |
| 3 | Initial insider ownership | Jan 25, 2024 | Jan 25, 2024 |
| 3 | Initial insider ownership | Jan 25, 2024 | Jan 25, 2024 |
| 3 | Initial insider ownership | Jan 25, 2024 | Jan 25, 2024 |
| 3 | Initial insider ownership | Jan 25, 2024 | Jan 25, 2024 |
| 3 | Initial insider ownership | Jan 25, 2024 | Jan 25, 2024 |
| 3 | Initial insider ownership | Jan 25, 2024 | Jan 25, 2024 |
| 3 | Initial insider ownership | Jan 25, 2024 | Jan 25, 2024 |
| 3 | Initial insider ownership | Jan 25, 2024 | Jan 25, 2024 |
| 3 | Initial insider ownership | Jan 25, 2024 | Jan 25, 2024 |
| 3 | Initial insider ownership | Jan 25, 2024 | Jan 25, 2024 |
| S-1MEF | Filing | Jan 25, 2024 | — |
| CERT | Filing | Jan 25, 2024 | — |
| S-1/A | Amended registration statement | Jan 23, 2024 | — |
| 8-A12B | Filing | Jan 23, 2024 | — |
| CORRESP | Letter to the SEC | Jan 23, 2024 | — |
| CORRESP | Letter to the SEC | Jan 23, 2024 | — |
| CORRESP | Letter to the SEC | Jan 22, 2024 | — |
| S-1/A | Amended registration statement | Jan 22, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 12, 2024 | — |
| CORRESP | Letter to the SEC | Jan 11, 2024 | — |
| S-1 | Registration statement | Jan 5, 2024 | — |
| DRS/A | Filing | Dec 6, 2023 | — |
| DRSLTR | Filing | Dec 5, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2023 | — |
| DRSLTR | Filing | Oct 31, 2023 | — |
| DRS/A | Filing | Oct 31, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 18, 2023 | — |
| SEC STAFF LETTER | Filing | Oct 13, 2023 | — |
| DRSLTR | Filing | Oct 4, 2023 | — |
| DRS/A | Filing | Oct 4, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 27, 2023 | — |
| DRS | Filing | Aug 25, 2023 | — |
| D | Filing | Dec 29, 2022 | — |
| D/A | Filing | Feb 14, 2022 | — |
| D | Filing | Jun 23, 2021 | — |
Showing 160 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AVBP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Newtown Square, PA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1868279
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.